Amang Rodriguez Memorial Medical Center

Results 1 - 12 of 12
Public Title Project Description Modified
A 24-week phase III randomized, double-blind, parallel group study to evaluate the efficacy and safe . . . This randomised, double-blind, multi-national, active-controlled, parallel group trial will evaluate . . . 01 Sep 2015 04:37:39
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURI . . . The primary hypothesis is that additional LDL-C lowering with AMG 145 when used in addition to other . . . 08 Apr 2016 09:34:32
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardi . . . The drug being tested in this study is called TAK-875. TAK-875 is being tested to treat people who h . . . 24 Aug 2014 11:09:23
Comparison of TAK-875 With Sitagliptin When Used in Combination With Metformin in Patients With Type . . . "The drug being tested in this study is called TAK-875. TAK-875 is being tested to treat people who . . . 02 May 2014 11:04:27
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Cardiovascular Outcomes . . . This trial is a multicenter, randomized, double-blind, placebo-controlled, event-driven trial that i . . . 18 Feb 2019 02:31:05
MK-8835/PF-04971729 vs. Placebo in T2DM Subjects with Stage 3 Chronic Kidney Disease This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial o . . . 03 Sep 2014 10:24:50
MK-8835/PF-04971729 vs. Glimepiride in T2DM Subjects on Metformin This is a multicenter, randomized, double-blind, active-comparator-controlled parallel-group clinica . . . 03 Sep 2014 10:25:44
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Ca . . . The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect . . . 26 Oct 2018 03:38:03
Phase 3, Randomized, double-blind, placebo-controlled, 26 week multicenter study to evaluate the eff . . . Phase 3 multi-center, randomized, parallel-group study with a 26-week,double-blind, placebo-controll . . . 17 Dec 2018 02:13:19
Randomized Sitagliptin Withdrawal Study (MK-0431-845) This is a trial of continuing sitagliptin versus withdrawing sitagliptin in participants with Type 2 . . . 23 May 2019 09:32:39
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Pa . . . This is an international, multicentre, event-driven, randomized, double-blind, parallel group, place . . . 24 Feb 2017 02:30:44
A multicenter, randomized, double-blind, active-controlled, parallel-group phase 3 study to evaluat . . . A multicenter, randomized, double-blind, active-controlled, parallel-group phase 3 study to evaluat . . . 07 Jul 2017 09:21:11

Copyright © One Window Project 2018. All rights reserved.